Literature DB >> 8133346

How do physicians weigh iatrogenic complications?

B J Cohen1, S G Pauker.   

Abstract

OBJECTIVE: To determine how physicians weigh iatrogenic complications when making clinical decisions.
DESIGN: Physicians were mailed a questionnaire describing two simplified scenarios--one involving a patient with a cerebral embolism and the other involving a patient with a life-threatening arrhythmia. In each scenario there was one potential natural adverse outcome (which could be prevented with drug therapy) and one potential drug side effect (iatrogenic adverse outcome), which would be clinically indistinguishable from the natural adverse outcome. Half the respondents were given the probability of the natural adverse outcome (PN) and were asked to specify the probability of the iatrogenic adverse outcome (PI) at which they felt that giving and withholding the therapy were equivalent strategies. The other respondents were given the PI and asked to specify the PN at which they felt the two strategies were equivalent.
SETTING: Academic medical center. PARTICIPANTS: Staff physicians.
MEASUREMENTS AND MAIN RESULTS: Results are expressed as the ratio PI/PN at which the respondent felt that giving and not giving therapy were equivalent strategies. A ratio less than 1 indicates that errors of commission (iatrogenic adverse outcomes) were given more weight than were errors of omission (natural adverse outcomes when therapy was withheld). Ratios less than 1 were provided in 56% of the responses (n = 230). The mean PI/PN in the group with ratios less than 1 was 0.53 +/- 0.26 (SD; n = 129).
CONCLUSIONS: In making decisions, some physicians appear to weigh errors of commission more heavily than they do errors of omission, while others weigh them equally. This diversity of physicians' attitudes may explain some of the variation observed in clinical practice in settings where The possibility of iatrogenic complications is of concern.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8133346     DOI: 10.1007/bf02599137

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  5 in total

1.  Clinical reasoning and cognitive processes.

Authors:  J C Hershey; J Baron
Journal:  Med Decis Making       Date:  1987 Oct-Dec       Impact factor: 2.583

2.  Comparison of physicians' decisions regarding estrogen replacement therapy for menopausal women and decisions derived from a decision analytic model.

Authors:  A S Elstein; G B Holzman; M M Ravitch; W A Metheny; M M Holmes; R B Hoppe; M L Rothert; D R Rovner
Journal:  Am J Med       Date:  1986-02       Impact factor: 4.965

3.  The 'chagrin factor' and qualitative decision analysis.

Authors:  A R Feinstein
Journal:  Arch Intern Med       Date:  1985-07

4.  On the elicitation of preferences for alternative therapies.

Authors:  B J McNeil; S G Pauker; H C Sox; A Tversky
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

5.  The framing of decisions and the psychology of choice.

Authors:  A Tversky; D Kahneman
Journal:  Science       Date:  1981-01-30       Impact factor: 47.728

  5 in total
  4 in total

1.  Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives.

Authors:  Pablo Alonso-Coello; Victor M Montori; M Gloria Díaz; Philip J Devereaux; Gemma Mas; Ana I Diez; Ivan Solà; Mercè Roura; Juan C Souto; Sven Oliver; Rafael Ruiz; Blanca Coll-Vinent; Ignasi Gich; Holger J Schünemann; Gordon Guyatt
Journal:  Health Expect       Date:  2014-05-12       Impact factor: 3.377

2.  Canadian atrial fibrillation anticoagulation study: were the patients subsequently treated with warfarin? Canadian Atrial Fibrillation Anticoagulation Study Group.

Authors:  A Laupacis; K Sullivan
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

3.  Is there an omission effect in prosocial behavior? A laboratory experiment on passive vs. active generosity.

Authors:  Manja Gärtner; Anna Sandberg
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

4.  Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study.

Authors:  Pablo Alonso-Coello; Victor M Montori; Ivan Solà; Holger J Schünemann; Philipe Devereaux; Cathy Charles; Mercè Roura; M Gloria Díaz; Juan Carlos Souto; Rafael Alonso; Sven Oliver; Rafael Ruiz; Blanca Coll-Vinent; Ana Isabel Diez; Ignasi Gich; Gordon Guyatt
Journal:  BMC Health Serv Res       Date:  2008-10-27       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.